Farther Finance Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$22.2K	Buy	2,481 +19	+0.8%	+$170	﹤0.01%	2607
2025 Q1	$17.9K	Buy	+2,462	New	+$17.9K	﹤0.01%	2442
2024 Q2	–	Sell	-60	Closed	-$303	–	3829
2024 Q1	$303	Buy	+60	New	+$303	﹤0.01%	3161